Clinical Progress and Risk Factors for Death from Severe Fever with Thrombocytopenia Syndrome: A Multihospital Retrospective Investigation in Anhui, China
- 7 April 2021
- journal article
- research article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 104 (4), 1425-1431
- https://doi.org/10.4269/ajtmh.20-0270
Abstract
Knowledge of the clinical progress of severe fever with thrombocytopenia syndrome (SFTS) and the associated predictors of mortality is important for providing appropriate treatment in severe cases. A multihospital retrospective study was conducted in three SFTS-endemic cities, in 2018. Of the 208 SFTS-confirmed cases, there were 189 survivors and 19 deaths. The median age was 64 years; 104 (50.0%) patients were men, and 188 (90.4%) were farmers. Furthermore, 203 (97.6%) patients reported fever and 70 (33.7%) reported fatigue. Most fatal cases had complications including multiple-organ failure, central nervous syndrome (CNS) abnormalities, and disseminated intravascular coagulation. During the fever phase, alanine transaminase, aspartate aminotransferase (AST), blood urea nitrogen (BUN), creatinine, D-dimer, glucose, hydroxybutyrate dehydrogenase, lactate dehydrogenase (LDH), procalcitonin, prothrombin time, and uric acid levels were higher in fatal than in nonfatal cases (P < 0.05). Creatine kinase (CK), CK-MB (CKMB), AST, and LDH levels were significantly lower in nonfatal than in fatal cases (P < 0.05). Central nervous syndrome abnormalities (odds ratio [OR] = 20.9, 95% CI: 4.3, 100), body temperature ≥ 38.5°C (OR = 23.2, 95% CI: 3.4, 158), BUN levels ≥ 6.4 mmol/L (OR = 9.9, 95% CI: 2.2, 44), CKMB levels ≥ 100 U/L (OR = 33.2, 95% CI: 5.8, 192), and LDH levels ≥ 1,000 U/L (OR = 8.3, 95% CI: 1.9, 37) were predictors of mortality. Our findings reveal that the presence of specific complications and laboratory parameters may serve as predictors of mortality and aid in early identification of severe SFTS cases in clinical practice.This publication has 29 references indexed in Scilit:
- Clinical progression and predictors of death in patients with severe fever with thrombocytopenia syndrome in ChinaJournal of Clinical Virology, 2014
- Clinical Features and Factors Associated with Severity and Fatality among Patients with Severe Fever with Thrombocytopenia Syndrome Bunyavirus Infection in Northeast ChinaPLOS ONE, 2013
- Case-Fatality Ratio and Effectiveness of Ribavirin Therapy Among Hospitalized Patients in China Who Had Severe Fever With Thrombocytopenia SyndromeClinical Infectious Diseases, 2013
- An emerging hemorrhagic fever in China caused by a novel bunyavirus SFTSVScience China Life Sciences, 2013
- Clinical and Epidemiological Study on Severe Fever with Thrombocytopenia Syndrome in Yiyuan County, Shandong Province, ChinaThe American Journal of Tropical Medicine and Hygiene, 2013
- Clinical Progress and Risk Factors for Death in Severe Fever with Thrombocytopenia Syndrome PatientsThe Journal of Infectious Diseases, 2012
- Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57/BL6 mouse modelProceedings of the National Academy of Sciences of the United States of America, 2012
- Severe Fever with Thrombocytopenia Syndrome Virus, Shandong Province, ChinaEmerging Infectious Diseases, 2012
- Fever with Thrombocytopenia Associated with a Novel Bunyavirus in ChinaThe New England Journal of Medicine, 2011
- Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and preventionVeterinary Research, 2010